Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Novartis executive sold shares before drug data manipulation made public

An unnamed Novartis executive sold 925,400 Swiss francs ($946,000) worth of shares less than three weeks before the U.S. Food and Drug Administration announced data from tests of the company’s gene therapy Zolgensma had been manipulated.

Read More »

Novartis names new head of U.S. drugs business

Novartis named company veteran Victor Bulto as head of the Swiss drugmaker’s U.S. pharmaceuticals business, effective Sept. 1, 2019.

Read More »

CureVac and Yale Team Up for mRNA-Based Lung Therapies

Tubingen, Germany-based CureVac entered a collaboration research agreement with Yale University to focus on lung therapies.

Read More »

Harvard, Merck Collaboration Aims to Discover New Immuno-oncology Targets

Harvard University and Merck launched a collaboration that will provide significant research funding for up to four years to support immuno-oncology research led by Arlene Sharpe, MD, PhD, at Harvard Medical School (HMS).

Read More »

Jazz Pharmaceuticals Announces Acquisition of Cavion

Jazz Pharmaceuticals plc announced the acquisition of clinical-stage biotechnology company Cavion Inc. through a merger with a Jazz subsidiary.

Read More »

AI Special Feature: In Pursuit of Artificial Empathy

Despite the benefits empathetic responses can deliver, our industry has yet to fully embrace its integration in the digital space.

Read More »

AI Special Feature: Artificial Intelligence and the Future of Medical Information Services

We do have more power at our fingertips than generations before us. But witnessing the rise of AI and actually experiencing it are two different realities.

Read More »

AR/VR Special Feature 2019: Augmenting pharma

Med Ad News spoke with digital guru Fabio Gratton about the present and future of augmented and virtual reality technologies in pharma and healthcare.

Read More »

AR/VR Special Feature 2019 – Game changer: The role of immersive technologies in the healthcare and pharmaceutical industries

The next decade promises to be an exciting time for science and innovation. Technological advancements are being made on a daily basis and many of these have the potential to directly impact our everyday lives. In fact, technology is changing at such a rate that it can often seem difficult to keep up.

Read More »

AR/VR Special Feature 2019: Augmented reality finds its stride

As augmented reality (AR) technology continues to mature, more life science companies are expanding its use, enabling a new class of innovative content for field teams to bring treatments to light. Whether demonstrating a new therapy, showing how a new medical device works or providing details about a complex disease state, AR can improve customer engagement, education and brand differentiation.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom